Navellier & Associates Inc. Has $8.65 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Navellier & Associates Inc. raised its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 4.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 14,552 shares of the biotechnology company’s stock after purchasing an additional 674 shares during the period. Axon Enterprise makes up 1.0% of Navellier & Associates Inc.’s portfolio, making the stock its 20th biggest holding. Navellier & Associates Inc.’s holdings in Axon Enterprise were worth $8,649,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Prestige Wealth Management Group LLC raised its position in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC bought a new position in Axon Enterprise during the 4th quarter worth $40,000. Brooklyn Investment Group bought a new position in Axon Enterprise during the 3rd quarter worth $41,000. Y.D. More Investments Ltd acquired a new position in Axon Enterprise in the 4th quarter valued at $45,000. Finally, Planning Capital Management Corp lifted its position in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 55 shares during the period. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 5.3 %

Shares of AXON stock opened at $513.22 on Friday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $39.13 billion, a P/E ratio of 132.62, a P/E/G ratio of 5.43 and a beta of 1.05. Axon Enterprise, Inc. has a twelve month low of $265.32 and a twelve month high of $715.99. The stock’s fifty day simple moving average is $619.94 and its 200 day simple moving average is $517.11.

Analysts Set New Price Targets

AXON has been the topic of a number of recent analyst reports. TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northland Securities upped their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday. Finally, Robert W. Baird boosted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $561.31.

Insider Transactions at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the sale, the director now directly owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 8,711 shares of company stock worth $5,631,561. Insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.